We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $100M
This Fund
S&P 500
This Quarter Est. Return
+10.1%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$101M
AUM Growth
+$3.77M
Cap. Flow
-$171K
Cap. Flow %
-0.17%
Top 10 Hldgs %
22.09%
Holding
226
New
42
Increased
62
Reduced
36
Closed
61

Top Buys

Rank Stock Value
1
NVAX icon
Novavax
NVAX
+$1.85M
2
CINC
CinCor Pharma, Inc. Common Stock
CINC
+$1.67M
3
TSVT
2seventy bio
TSVT
+$1.59M
4
ARQT icon
Arcutis Biotherapeutics
ARQT
+$1.37M
5
ADCT icon
ADC Therapeutics
ADCT
+$1.19M

Top Sells

Rank Stock Value
1
SHY icon
iShares 1-3 Year Treasury Bond ETF
SHY
+$12.8M
2
IWD icon
iShares Russell 1000 Value ETF
IWD
+$2.1M
3
RPV icon
Invesco S&P 500 Pure Value ETF
RPV
+$2.08M
4
WBA
Walgreens Boots Alliance
WBA
+$1.6M
5
SNY icon
Sanofi
SNY
+$1.56M

Sector Composition

Rank Sector Weight
1 Healthcare 56.8%
2 Real Estate 15.08%
3 Financials 8.32%
4 Energy 6.75%
5 Industrials 3.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AFL icon
101
Aflac
AFL
$63.5B
$284K 0.28%
+3,954
New +$265K
GL icon
102
Globe Life
GL
$14.3B
$284K 0.28%
+2,358
New +$270K
JNJ icon
103
Johnson & Johnson
JNJ
$609B
$282K 0.28%
+1,596
New +$276K
UNH icon
104
UnitedHealth
UNH
$387B
$281K 0.28%
530
+109
+26% +$57.7K
MCK icon
105
McKesson
MCK
$98.5B
$279K 0.28%
+743
New +$277K
PGR icon
106
Progressive
PGR
$121B
$278K 0.28%
+2,147
New +$272K
COR icon
107
Cencora
COR
$59.9B
$278K 0.27%
1,678
+346
+26% +$54.7K
WRB icon
108
W.R. Berkley
WRB
$26.7B
$278K 0.27%
5,742
+1,176
+26% +$56.7K
ABBV icon
109
AbbVie
ABBV
$450B
$274K 0.27%
1,693
+358
+27% +$54.9K
HPE icon
110
Hewlett Packard
HPE
$60.7B
$272K 0.27%
17,013
-287
-2% -$4.23K
PEP icon
111
PepsiCo
PEP
$187B
$270K 0.27%
1,496
+311
+26% +$55.5K
JKHY icon
112
Jack Henry & Associates
JKHY
$10.8B
$269K 0.27%
+1,532
New +$283K
DHI icon
113
D.R. Horton
DHI
$42.4B
$267K 0.26%
3,000
– –
GPC icon
114
Genuine Parts
GPC
$17.2B
$267K 0.26%
+1,539
New +$268K
HSY icon
115
Hershey
HSY
$34.8B
$265K 0.26%
1,144
+237
+26% +$54.6K
IMO icon
116
Imperial Oil
IMO
$59.2B
$265K 0.26%
5,431
-26
-0.5% -$1.34K
CVX icon
117
Chevron
CVX
$373B
$263K 0.26%
+1,463
New +$255K
AMGN icon
118
Amgen
AMGN
$198B
$261K 0.26%
+992
New +$266K
NUE icon
119
Nucor
NUE
$53.9B
$256K 0.25%
1,939
-1,798
-48% -$244K
K
120
DELISTED
Kellanova
K
$255K 0.25%
3,812
+801
+27% +$54.4K
BMY icon
121
Bristol-Myers Squibb
BMY
$124B
$253K 0.25%
+3,518
New +$265K
RSG icon
122
Republic Services
RSG
$68.4B
$253K 0.25%
1,961
+404
+26% +$53.9K
KO icon
123
Coca-Cola
KO
$351B
$252K 0.25%
3,963
+828
+26% +$50K
NMZ icon
124
Nuveen Municipal High Income Opportunity Fund
NMZ
$2.22B
$239K 0.24%
23,100
-900
-4% -$9.39K
NMCO icon
125
Nuveen Municipal Credit Opportunities Fund
NMCO
$599M
$237K 0.23%
21,550
-1,000
-4% -$11.1K
3 4
5
6 7

Similar funds

WCM
Weber Capital Management San Francisco, California $100M AUM
FCM
Fourier Capital Management Hong Kong $100M AUM
BIA
Baer Investment Advisory Corte Madera, California $100M AUM 23.87% 1-Year Est. Return
AGAM
Audent Global Asset Management West Hollywood, California $100M AUM 22.83% 1-Year Est. Return
E
Entelevest Coral Gables, Florida $100M AUM
HCM
Hicks Capital Management Columbus, Ohio $100M AUM 14.29% 1-Year Est. Return
AC
Arrow Capital Sydney, Australia $100M AUM 68.52% 1-Year Est. Return
OIS
OneAscent Investment Solutions Birmingham, Alabama $100M AUM 15.97% 1-Year Est. Return

AlphaCentric Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, AlphaCentric Advisors held 226 positions worth $101M, up 3.9% from $97.4M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

AlphaCentric Advisors's Q4 2022 filing shows 42 new, 62 increased, 36 reduced and 61 closed positions. Its largest new stake was Novavax: 105,000 shares worth $1.08M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $12.8M.

By sector, the portfolio is most concentrated in Healthcare at 57% of assets, up from 44% a quarter earlier, followed by Real Estate and Financials.

  • AlphaCentric Advisors's largest Q4 2022 buy was Novavax: 105,000 shares worth $1.08M.
  • AlphaCentric Advisors added most to 2seventy bio in Q4 2022, an estimated $1.59M increase.
  • AlphaCentric Advisors's biggest Q4 2022 reduction was Walgreens Boots Alliance, cutting an estimated $1.6M.
  • AlphaCentric Advisors fully exited iShares 1-3 Year Treasury Bond ETF in Q4 2022, selling an estimated $12.8M.
  • AlphaCentric Advisors's ten largest holdings make up 22% of its $101M portfolio in Q4 2022.
  • AlphaCentric Advisors opened 42 new positions and closed 61 in Q4 2022.
  • AlphaCentric Advisors's portfolio value rose 3.9% quarter-over-quarter to $101M.

Based on AlphaCentric Advisors's 13F filing for Q4 2022, filed 7 Feb 2023.